These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 1819809)

  • 41. Predicting and comparing long-term measles antibody profiles of different immunization policies.
    Lee MS; Nokes DJ
    Bull World Health Organ; 2001; 79(7):615-24. PubMed ID: 11477964
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
    [No Abstract]   [Full Text] [Related]  

  • 43. Abnormalities of measles antibody response in human immunodeficiency virus type 1 (HIV-1) infection.
    Brunell PA; Vimal V; Sandu M; Courville TM; Daar E; Israele V
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):540-8. PubMed ID: 8548333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay.
    Hamkar R; Mahmoodi M; Nategh R; Jelyani KN; Eslami MB; Mohktari-Azad T
    East Mediterr Health J; 2006 Nov; 12(6):775-82. PubMed ID: 17333822
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Postvaccinal immunity study of children inoculated with a live measles vaccine].
    Bol'shakova SL
    Tr Inst Im Pastera; 1979; 53():75-8. PubMed ID: 162466
    [No Abstract]   [Full Text] [Related]  

  • 47. [Analysis of the correlation between measles and subacute sclerosis panencephalitis (SSPE) before and after introduction of vaccination in Poland].
    Gut W; Naruszewicz-Lesiuk D
    Przegl Epidemiol; 1992; 46(4):295-301. PubMed ID: 1305779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the eight-year period of compulsory measles vaccination in the Czech Socialist Republic (CSR).
    Sejda J
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(3):273-83. PubMed ID: 575149
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determination of measles hemagglutination inhibiting antibody levels among school children in Ibadan, Nigeria.
    Ogundiji OT; Okonko IO; Adu FD
    J Immunoassay Immunochem; 2013; 34(2):208-17. PubMed ID: 23537304
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Efficacy evaluation of measles vaccine in fields].
    Liu M
    Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Oct; 12(5):292-4. PubMed ID: 1782660
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Wild measles virus strain: isolation and identification.
    Tikhonova NT; Mamaeva TA; Naumova MA; Leschinskaja EV; Volkov MV; Martynenko IM
    Acta Virol; 1992 Dec; 36(6):557-66. PubMed ID: 1363990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Maternal screening and postpartum vaccination for measles infection in Japan: a cohort study.
    Shoda A; Hayashi M; Takayama N; Oshima K; Nishikawa M; Okazaki T; Negishi M; Hayashida S; Watanabe H; Inaba N
    BJOG; 2011 Jan; 118(1):88-92. PubMed ID: 21197682
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Presence of IgG class antibodies anti-measles virus in sera of subjects in different age].
    Cześcik A; Dunal M; Trzcińska A; Siennicka J
    Med Dosw Mikrobiol; 2012; 64(1):73-8. PubMed ID: 22808732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measles outbreak in Ibadan: clinical, serological and virological identification of affected children in selected hospitals.
    Adu FD; Ikusika A; Omotade O
    J Infect; 1997 Nov; 35(3):241-5. PubMed ID: 9459395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Persistence of measles antibody two years after revaccination by aerosol or subcutaneous routes.
    Dilraj A; Cutts FT; Bennett JV; Fernandez de Castro J; Cohen B; Coovadia HM
    Pediatr Infect Dis J; 2000 Dec; 19(12):1211-3. PubMed ID: 11144388
    [No Abstract]   [Full Text] [Related]  

  • 56. [Anti-measles humoral immunity in children with thymus hyperplasia].
    Gurvich EB; Lysenkova NV; Shishatskaia SN; Vaganov PD; Ozeretskovskiĭ NA
    Pediatriia; 1989; (9):31-3. PubMed ID: 2587164
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Immunologic evaluation of measles vaccine in preschool and school children].
    Soto C; Cordero J; Vergara MI
    Rev Chil Pediatr; 1981; 52(6):491-5. PubMed ID: 7347862
    [No Abstract]   [Full Text] [Related]  

  • 58. [Investigation of antibodies against measles antigen in institutionalized patients with severe motor and intellectual disability].
    Machida Y; Yamamoto J; Yano Y; Yano T
    Kansenshogaku Zasshi; 2008 Jul; 82(4):328-34. PubMed ID: 18697485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Response of viral specific CD4 T cells to in vitro stimulation with vaccine and wild measles virus strains in vaccinated and naturally infected subjects.
    Cześcik A; Dunal-Szczepaniak M; Trzcińska A; Siennicka J
    Pol J Microbiol; 2014; 63(2):203-9. PubMed ID: 25115114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Efficacy of specific prophylaxis against measles].
    Andzhaparidze OG; Gordienko HM; Sokolova TM; Dorofeev VM
    Vestn Akad Med Nauk SSSR; 1975; (4):27-33. PubMed ID: 1220365
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.